Antiproteinuric therapy and fabry nephropathy: sustained reduction of proteinuria in patients receiving enzyme replacement therapy with agalsidase-beta.

Source:http://linkedlifedata.com/resource/pubmed/id/17656478

Download in:

View as

General Info

PMID
17656478